Stockscreener 앱 받기
6.82
3.18%
0.21
시간 외 거래:
6.86
0.04
+0.59%
전일 마감가:
$6.61
열려 있는:
$6.67
하루 거래량:
2.88M
Relative Volume:
1.44
시가총액:
$309.95M
수익:
$193.06M
순이익/손실:
$-22.51M
주가수익비율:
-10.66
EPS:
-0.64
순현금흐름:
$10.63M
1주 성능:
-31.39%
1개월 성능:
-43.02%
6개월 성능:
+4.44%
1년 성능:
+30.65%
1일 변동 폭
$6.6537
$7.10
1주일 범위
$6.25
$12.72
52주 변동 폭
$3.99
$15.84
Lifemd Inc Stock (LFMD) Company Profile
명칭
Lifemd Inc
전화
(866) 351-5907
주소
236 FIFTH AVENUE, NEW YORK
LFMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LFMD
Lifemd Inc
|
6.82 | 294.10M | 193.06M | -22.51M | 10.63M | -0.64 |
|
VEEV
Veeva Systems Inc
|
282.13 | 46.19B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
60.87 | 9.61B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
66.58 | 10.89B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
93.05 | 7.86B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
34.59 | 5.92B | 906.14M | -52.62M | 89.62M | -0.3621 |
Lifemd Inc Stock (LFMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-18 | 재확인 | BTIG Research | Buy |
| 2024-12-10 | 개시 | Lake Street | Buy |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-08-23 | 재개 | B. Riley Securities | Buy |
| 2024-06-05 | 개시 | KeyBanc Capital Markets | Overweight |
| 2023-11-30 | 개시 | Craig Hallum | Buy |
| 2023-07-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-07-03 | 개시 | H.C. Wainwright | Buy |
| 2022-03-10 | 개시 | Colliers Securities | Buy |
| 2021-10-04 | 재개 | B. Riley Securities | Buy |
모두보기
Lifemd Inc 주식(LFMD)의 최신 뉴스
Is LifeMD Inc. a top pick in the sectorBuyback Announcements Stock Watch - thegnnews.com
LifeMD price target lowered to $13 from $14 at H.C. Wainwright - TipRanks
LifeMD, Inc. (NASDAQ:LFMD) Q2 2025 Earnings Call Transcript - Insider Monkey
Positive Sentiment Still Eludes LifeMD, Inc. (NASDAQ:LFMD) Following 46% Share Price Slump - simplywall.st
LifeMD Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
LifeMD (LFMD) Target Price Lowered by HC Wainwright & Co. to $13 - GuruFocus
LifeMD’s Strong Growth Potential and Strategic Diversification Support Buy Rating Despite Revenue Guidance Adjustment - TipRanks
LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates - MSN
LifeMD Earnings Call: Mixed Sentiments and Strategic Moves - TipRanks
LifeMD Stock Plummets 40%. Why Weight Loss Isn't Just A Gimme. - Investor's Business Daily
LifeMD stock price target lowered to $12 at KeyBanc on elevated costs - Investing.com
LifeMD price target lowered to $14 from $18 at Lake Street - TipRanks
LifeMD Misses Estimates, But Keeps Growing And Diversifying - Finimize
Lake Street Initiates LifeMD(LFMD.US) With Buy Rating, Announces Target Price $14 - 富途牛牛
LifeMD Plummets 44%: A Telehealth Titan's Turbulent Turnaround? - AInvest
LifeMD (LFMD) Analyst Lowers Price Target but Maintains Overweig - GuruFocus
LifeMD Plummets 40.96%: Earnings Shock and Sector Headwinds Spark Investor Exodus - AInvest
LifeMD slumps after firm cuts 2025 revenue forecast - TradingView
TR | OpenAI4o Maintains LifeMD(LFMD.US) With Hold Rating, Cuts Target Price to $12.5 - 富途牛牛
KeyBanc Adjusts LifeMD (LFMD) Price Target Amid Business Strateg - GuruFocus
LifeMD 2025 Q2 Earnings Significant Loss Reduction - AInvest
LifeMD (LFMD) Q2 Revenue Rises 23% - The Globe and Mail
LifeMD, Inc. Reports Strong Q2 2025 Growth - TipRanks
LifeMD’s CEO Makes a Bold Move with Significant Stock Sale - TipRanks
LifeMD's Q2 2025 Earnings Call: Navigating Contradictions in Insurance Strategy and Customer Acquisition Costs - AInvest
LifeMD (LFMD) Revenues and Earnings Miss Expectations - GuruFocus
LifeMD (LFMD) Updates Financial Guidance Amid Revenue Growth - GuruFocus
Earnings call transcript: LifeMD Q2 2025 misses expectations, stock dips - Investing.com
LifeMD CEO Schreiber sells $249,690 in shares By Investing.com - Investing.com Nigeria
LifeMD CEO Schreiber sells $249,690 in shares - Investing.com
LifeMD August 2025 slides: Virtual healthcare platform targets $255M in 2025 revenue - Investing.com Canada
LifeMD August 2025 slides: Virtual healthcare platform targets $255M in 2025 revenue By Investing.com - Investing.com South Africa
LifeMD reports Q2 EPS (6c) vs. (19c) last year - TipRanks
LifeMD shares plunge as Q2 results miss, guidance cut By Investing.com - Investing.com Canada
LifeMD cuts FY25 revenue view to $250M-$255M from $268M-$275M - TipRanks
LifeMD earnings missed by $0.04, revenue fell short of estimates - Investing.com Canada
LifeMD Reports Second Quarter 2025 Results - GlobeNewswire
LifeMD Inc (LFMD) Q2 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
LifeMD to Participate in the Canaccord Genuity 45th Annual Growth Conference - GlobeNewswire
When is LifeMD Inc. stock expected to show significant growthExceptional market performance - Jammu Links News
Does LifeMD Inc. stock perform well during market downturnsDiscover stocks with massive upside potential - Jammu Links News
What analysts say about LifeMD Inc. stockMaximize your returns with smart trade entries - Jammu Links News
What are analysts’ price targets for LifeMD Inc. in the next 12 monthsIdentify undervalued stocks ready to soar - Jammu Links News
How does LifeMD Inc. compare to its industry peersBuild wealth with proven stock investing tactics - Jammu Links News
Is it the right time to buy LifeMD Inc. stockMaximize gains with strategic stock entries - Jammu Links News
What are LifeMD Inc. company’s key revenue driversHigh-yield portfolio picks - Jammu Links News
Why is LifeMD Inc. stock attracting strong analyst attentionCapitalize on momentum-driven investment opportunities - Jammu Links News
What are the latest earnings results for LifeMD Inc.Spectacular growth rates - Jammu Links News
What are the technical indicators suggesting about LifeMD Inc.Identify undervalued stocks ready to soar - Jammu Links News
What is the dividend policy of LifeMD Inc. stockUnlock exclusive investment alerts - Jammu Links News
Is LifeMD Inc. stock overvalued or undervaluedBuild a strong portfolio for growth and safety - Jammu Links News
Lifemd Inc (LFMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.97%
6.08%
자본화:
|
볼륨(24시간):